TNFSF10 and cancer: Over the past 10 years, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has emerged as a promising candidate for cancer therapy based on inducing apoptosis specifically in various tumor cells without significant toxicity toward normal cells [16, 17].